Metadata
- Name
- Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT01423851
- Description
- The purpose of this study is to determine the safety and tolerability of orally administered
NS-018 in patients with Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis
(post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (post-ET MF) - Data or Study Types
- clinical trial
- Keywords
- Thrombocythemia, Essential, Keywords provided by NS Pharma, Inc.:, Hematologic Diseases, post-Essential Thrombocythemia Myelofibrosis, JAK2 kinase inhibitor, Primary Myelofibrosis, NS-018, post-ET MF, PMF, post-Polycythemia Vera Myelofibrosis, post-PV MF, Polycythemia Vera, Bone Marrow Diseases, Additional relevant MeSH terms:, Myeloproliferative Neoplasms
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2011
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT01423851
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT01423851